What does an Amniotic Fluid Index (AFI) of 20.89 indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amniotic Fluid Index of 20.89 cm: Clinical Significance

An Amniotic Fluid Index (AFI) of 20.89 cm indicates increased amniotic fluid volume but falls within the normal range (5-24 cm) as defined by the American College of Radiology, though it is approaching the upper threshold for polyhydramnios. 1

Understanding AFI Measurement and Normal Ranges

  • AFI is measured by summing the deepest vertical pocket of amniotic fluid in each of the four quadrants of the uterus, providing a quasi-quantitative assessment of amniotic fluid volume 1
  • The normal range for AFI is 5-24 cm, with values below 5 cm indicating oligohydramnios and values above 24 cm indicating polyhydramnios 1
  • AFI values vary throughout pregnancy, with a progressive rise until 26 weeks, followed by relative stability until 38 weeks, after which there is a gradual decline 2, 3

Clinical Interpretation of AFI 20.89

  • At 20.89 cm, this AFI value is elevated but still within normal limits, approaching the upper threshold of 24 cm 1
  • This value represents approximately:
    • 524 mL of amniotic fluid at 20 weeks
    • 848 mL of amniotic fluid at 30 weeks
    • 723 mL of amniotic fluid at 34 weeks 4
  • While not meeting the strict definition of polyhydramnios (>24 cm), this elevated value warrants clinical attention as it approaches the 95th percentile for most gestational ages 5

Clinical Implications and Monitoring

  • Although within normal range, an AFI of 20.89 cm may indicate a trend toward excess amniotic fluid that should be monitored 1
  • If the current AFI is >8 cm (as in this case), the risk of developing oligohydramnios within 7 days is only 2.2%, suggesting weekly assessments would be adequate for follow-up 6
  • AFI is an essential component of the modified Biophysical Profile (mBPP) for ongoing fetal surveillance 1
  • The clinical context should be considered, as AFI values vary slightly by maternal race/ethnicity, though these differences may not be clinically significant 5

Considerations for Fetal Assessment

  • An elevated but normal AFI should be interpreted alongside other fetal assessment parameters, including estimated fetal weight and Doppler studies 7
  • If other parameters are normal, this AFI alone would not typically trigger delivery or intervention before 37 weeks 7
  • Continued surveillance with weekly AFI measurements is appropriate given the value is elevated but not meeting polyhydramnios criteria 6

Alternative Measurement Considerations

  • Some evidence suggests that the Maximum Vertical Pocket (MVP) may perform better than AFI for clinical decision making 1
  • Normal MVP is defined as ≥ 2 cm throughout gestation 1
  • Consider incorporating MVP measurement in future assessments as it may result in fewer unnecessary interventions 1

References

Guideline

Amniotic Fluid Index Measurement and Clinical Significance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Amniotic fluid index measurements during pregnancy.

The Journal of reproductive medicine, 1987

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.